skip to main
|
skip to sidebar
biosink
7.26.2007
Fresh from the FDA Dockets (DrugWonks)
Fresh from the FDA Dockets (DrugWonks)
: "This from the Glaxo data submission. I can bet you won't see this reported anywhere else:"
Newer Post
Older Post
Home
Blog Archive
►
2013
(14)
►
05/05 - 05/12
(1)
►
04/07 - 04/14
(9)
►
03/31 - 04/07
(1)
►
03/10 - 03/17
(3)
►
2010
(4)
►
06/13 - 06/20
(1)
►
01/31 - 02/07
(2)
►
01/10 - 01/17
(1)
►
2009
(22)
►
09/20 - 09/27
(2)
►
09/06 - 09/13
(1)
►
08/09 - 08/16
(1)
►
08/02 - 08/09
(1)
►
07/12 - 07/19
(1)
►
05/10 - 05/17
(2)
►
04/19 - 04/26
(5)
►
04/12 - 04/19
(1)
►
04/05 - 04/12
(7)
►
03/01 - 03/08
(1)
►
2008
(290)
►
12/28 - 01/04
(2)
►
12/21 - 12/28
(4)
►
12/14 - 12/21
(2)
►
11/23 - 11/30
(1)
►
10/26 - 11/02
(5)
►
10/19 - 10/26
(5)
►
10/12 - 10/19
(55)
►
10/05 - 10/12
(1)
►
09/28 - 10/05
(1)
►
09/21 - 09/28
(45)
►
09/14 - 09/21
(3)
►
08/31 - 09/07
(5)
►
08/24 - 08/31
(20)
►
08/17 - 08/24
(3)
►
08/10 - 08/17
(1)
►
08/03 - 08/10
(3)
►
07/13 - 07/20
(1)
►
07/06 - 07/13
(2)
►
06/29 - 07/06
(13)
►
06/15 - 06/22
(2)
►
06/08 - 06/15
(2)
►
06/01 - 06/08
(2)
►
05/25 - 06/01
(7)
►
05/18 - 05/25
(7)
►
05/11 - 05/18
(1)
►
04/27 - 05/04
(9)
►
04/20 - 04/27
(22)
►
04/13 - 04/20
(11)
►
04/06 - 04/13
(20)
►
03/30 - 04/06
(4)
►
03/23 - 03/30
(1)
►
03/16 - 03/23
(1)
►
03/09 - 03/16
(1)
►
02/24 - 03/02
(3)
►
02/17 - 02/24
(10)
►
02/10 - 02/17
(5)
►
02/03 - 02/10
(2)
►
01/27 - 02/03
(3)
►
01/13 - 01/20
(4)
►
01/06 - 01/13
(1)
▼
2007
(1218)
►
12/16 - 12/23
(4)
►
12/02 - 12/09
(5)
►
11/25 - 12/02
(4)
►
11/18 - 11/25
(22)
►
11/11 - 11/18
(31)
►
11/04 - 11/11
(10)
►
10/28 - 11/04
(4)
►
10/21 - 10/28
(15)
►
10/14 - 10/21
(31)
►
10/07 - 10/14
(85)
►
09/30 - 10/07
(129)
►
09/23 - 09/30
(23)
►
09/16 - 09/23
(98)
►
09/09 - 09/16
(116)
►
09/02 - 09/09
(52)
►
08/26 - 09/02
(57)
►
08/19 - 08/26
(52)
►
07/29 - 08/05
(40)
▼
07/22 - 07/29
(173)
Patent Docs: Biosimilars 2007 Conference
Patent Docs: Ranbaxy and GlaxoSmithKline Settle Va...
BioCryst Initiates Phase II Clinical Trial to Eval...
Sector Glance: Biotechnology - Forbes.com
Patent Law Jobs by Patently-O: Patent Counsel - Me...
Xconomy � Blog Archive � Reeves to Menino: Cambrid...
FDA Reviewer Rips Nissens (DrugWonks)
Health Blog : Merck's Vioxx Warrior Gets Promoted
Patent Prospector: Scratch & Sniff
Have I Been Misreading the FDA? (DrugWonks)
Sector Glance: Biotechnology - Forbes.com
Neogen Announces 3-for-2 Stock Split
Health Blog : FDA Committee Won't Consider Controv...
The Volokh Conspiracy - Lawsuit Challenging Qualif...
: "NEW DELHI: Riding on the success of Bt cotton, ...
Biolex Therapeutics Announces Positive Phase 2a Re...
Threshold Pharmaceuticals Initiates Phase 1 Clinic...
EntreMed Commences Leukemia Clinical Trial for MKC...
Peter Zura's 271 Patent Blog: Manufacturing and La...
FDA Drug Approval Statistics
Patent Prospector: Laboring over Patent Reform
Biotech Blog � Expanding the bandwidth of life sci...
Fresh from the FDA Dockets (DrugWonks)
Patent Law Blog (Patently-O): No Revival For "Unin...
Aspreva cuts a quarter of its jobs as it refocuses...
ADA Applauds Legislators for 'Meth Mouth' Bills
Cell Therapeutics inks deal to buy cancer drug dev...
Pfizer, Hydra strike $195M pain pact - FierceBiote...
Biotech CEOs face rising fury of angry investors -...
Faster, Easier Quantification of Secreted IgG Anti...
New compounds in works for tuberculosis - FierceBi...
Scientists plot first moves for Project Checkmate ...
Synthetic biology spawns fresh approach to antibio...
ALSO NOTED: Fat cells could be used to replace sil...
Reduced insulin signaling may halt aging, disease ...
Patch to replace heart transplants? - FierceBioRes...
ALSO NOTED: Geron faces critics' wrath;New diagnos...
Health Blog : An Ugly Saga of Politics and AIDS Wi...
Health Blog : Drug Companies Seize Tax Break, Cut ...
Health Blog : Japanese Takeout: Drug Making
ALSO NOTED: Advanced Magnetics touts Phase III dat...
Press Release: BioXell To Regain Rights To TREM Pl...
Health Blog : FDA Delays Decision on Wyeth Menopau...
Biosecurity expert points to threat of smallpox at...
Venter's latest revelation could save the world - ...
Health Blog : Goldman Gets Into Hospital Software
Cell Therapeutics, Inc. Announces $20.25 Million O...
Orange Book Blog: Federal Circuit Affirms Invalidi...
Health Blog : Insurers Put Money Behind Doctor Rat...
Evogene and CIRAD Expand Their Cotton Collaboration
SignOnSanDiego.com > News > Business -- Amylin rep...
US presses ahead with patent reforms - ZDNet UK
Sector Snap: Drug Companies - Forbes.com
Patent Docs: Organon and MRC Technology to Collabo...
Patent Docs: USPTO News: Patent Office Sends KSR T...
Patent Docs: USPTO News: New Continuation and Clai...
FDA Oncologic Drugs Advisory Committee Recommends ...
MaRS Blog - Innovation and Commercialization in Ca...
Patent Prospector: Dealing with KSR
Biotech Definitions: "Biotech DefinitionsBIO-INFOM...
Biotechnology in Texas
Protalex Announces Preliminary Results in Phase I ...
The Fire of Genius � A New Essay
Orexigen claims success in weight-loss trial - Fie...
Big Pharma brings home the cash, slices payroll - ...
New hope for cross-species transplantation - Fierc...
Controlling brain protein may modulate stress, moo...
Biotech pioneer bets a billion on Alzheimer's prog...
FDA demands more data on Wyeth's Pristiq - FierceB...
OilOnline - The Original Online Source for the Oil...
Alzheimer's Drug Discovery Foundation Invites Scie...
Fourth ACTEMRA(TM) (tocilizumab) Phase III Study D...
IPOX Schuster's New China IPO Index Focused On 'A'...
PharmaLive: DSM Biologics and Crucell Announce PER...
From the Sequencer to the Drugstore?. In the Pipel...
Patent Prospector: USPTO Rule Changes
Health Blog : The Science of Peppers and Pain
Pharma Marketing Blog: Why Do DTC Ads - "Viva Viag...
Health Blog : Glaxo's Earnings Steady, Despite Ava...
Patent Prospector: Silk Purse from a Sow's Ear
News: Arena Pharmaceuticals Initiates Phase 1 Clin...
A Farewell to Tin. In the Pipeline:
ScienceDaily: Study Urges Compensation-based Appro...
Health Blog : Building Family-Friendly ICUs
Want To Live Longer? Take New Drugs (DrugWonks)
Bioethics Crisis in China
News: Scientists Find Compound that Targets Therap...
Biotech Blog � Drug reimportation: Where are the d...
QLT announces FDA filing and review of Aczone(TM) ...
EpiCept Announces Phase III Study of EpiCept(TM) N...
GeekPress
SPOTLIGHT: Targeted Genetics study on hold - Fierc...
Anticipate This! EP-Oh! (Information about the Eur...
Patent Docs: Mergers and Acquisitions Are Preferre...
The IN VIVO Blog
Health Blog : Lab Values Predict Mortality for Hos...
Genstar inks $744M deal to buy PRA International -...
WuXi PharmaTech files $120M IPO on NYSE - FierceBi...
China pushes drug development as R&D soars - Fierc...
Merck snares NovaCardia in $350M buyout - FierceBi...
GPC cancer drug voted down by FDA committee - Fier...
Vertex Shares Rise on Telaprevir Outlook - Forbes.com
On to the FDA With a New Name
VentureBeat � InfoNgen, Netvibes for finance junkies
Sector Snap: Biotech Rises - Forbes.com
Add Cancer to the Laundry List of Statin Scares (D...
Personalized Medicine for Mental Illness (DrugWonks)
Amylin Pharmaceuticals Disappoints Analysts, But N...
ZARS Initiates Phase 3 Clinical Trial of ThermoProfen
Neurochem granted Fast Track designation from U.S....
PharmaLive: Report Predicts That Generics Will Lim...
Pipex Pharmaceuticals Soars on Business Week Featu...
Turning up the heat on biotech
Medivation Announces Treatment of First Patient in...
Peter Zura's 271 Patent Blog: Indian Article on Pa...
BioLineRx Initiates Phase II Trial of BL-1020, a F...
PharmaLive: Athersys Begins Phase I Trial for ATHX...
patent reform biotech and high tech Biotech vs. Hi...
Health Business Blog � Blog Archive � Grand Rounds...
Xconomy � Blog Archive � Can Harvard Match MIT at ...
BioCryst Initiates Phase II Clinical Trial to Eval...
Health Blog : Abbott Drops Cyber Case Against AIDS...
SignOnSanDiego.com > News > Business -- Venture ca...
Neurogesx: A Speculative Biotech Investment - Seek...
ev3 And FoxHollow Technologies Announce Merger - S...
www.kansascity.com | 07/23/2007 | Kansas City lags...
Baxter gets flu vaccine back on track -- chicagotr...
blogging various things biotech...: FuturePundit: ...
►
07/15 - 07/22
(24)
►
07/08 - 07/15
(10)
►
05/06 - 05/13
(7)
►
04/29 - 05/06
(76)
►
04/22 - 04/29
(150)